Ifosfamide (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Ifosfamide drug offered from Mylan Institutional LLC. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: Ifosfamide
SUBSTANCE NAME: IFOSFAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-11-27
END MARKETING DATE: 0000-00-00


Ifosfamide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIfosfamide from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 2012-11-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-429_4a2f8f58-5b87-44f9-aa33-28efd5064293
PRODUCT NDC: 67457-429
APPLICATION NUMBER: ANDA201689

Other IFOSFAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
APP Pharmaceuticals, LLCIfosfamide
Baxter Healthcare CorporationIFEX
Fresenius Kabi USA, LLCIfosfamide
Mylan Institutional LLCIfosfamide
Pfizer Laboratories Div Pfizer Inc.Ifosfamide
Teva Parenteral Medicines, Inc.Ifosfamide
West-Ward Pharmaceuticals CorpIfosfamide